| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:JC-171
CAS:2112809-98-8
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:JC-171
CAS:2112809-98-8
Package:2mg/RMB 2130;5mg/RMB 2490;10mg/RMB 4160
|
JC-171
(JC171) manufacturers
- JC-171
-
- $297.00 / 5mg
-
2024-10-28
- CAS:2112809-98-8
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | JC-171
(JC171) Basic information |
| Product Name: | JC-171
(JC171) | | Synonyms: | JC-171
(JC171);Benzamide, 5-chloro-N-[2-[4-[(hydroxyamino)sulfonyl]phenyl]ethyl]-2-methoxy- | | CAS: | 2112809-98-8 | | MF: | C16H17ClN2O5S | | MW: | 384.83 | | EINECS: | | | Product Categories: | | | Mol File: | 2112809-98-8.mol |  |
| | JC-171
(JC171) Chemical Properties |
| density | 1.401±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 250 mg/mL (649.64 mM) | | form | Solid | | pka | 6.43±0.69(Predicted) | | color | White to off-white |
| | JC-171
(JC171) Usage And Synthesis |
| Uses | JC-171 is a selective NLRP3 inflammasome inhibitor, with an IC50 of 8.45 μM for inhibiting LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages[1]. | | in vivo | JC-171 treatment delays the progression and reduces the severity of experimental autoimmune encephalomyelitis (EAE) in mouse[1]. | Animal Model: | Mice immunized subcutaneously with 200 μg Myelin oligodendrocyte glycoprotein (MOG) 35–55 peptide emulsified in Complete Freund’s Adjuvant (CFA) on day 0 followed by injection of 200 ng of pertussis toxin. | | Dosage: | 100 mg/kg, 10 mg/kg. | | Administration: | IP days 0, 1 and 2; and every other days thereafter (100 mg/kg).
Initiated when the clinical scores of individual mice have reached 1 (flaccid tail), and given every other day (10 mg/kg).
| | Result: | Efficiently suppressed EAE progression compared with vehicle treatment.
Resulted in a substantial decrease in the frequency of MOG35–55-specific Th17 cells in the spleens and spinal cords of EAE mice.
|
| | IC 50 | NLRP3 | | References | [1] Chunqing Guo, et al. Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis. ACS Chem Neurosci. 2017 Oct 18;8(10):2194-2201. DOI:10.1021/acschemneuro.7b00124 |
| | JC-171
(JC171) Preparation Products And Raw materials |
|